A detailed history of Nicolet Advisory Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Nicolet Advisory Services, LLC holds 3,254 shares of RGEN stock, worth $470,072. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,254
Previous 3,053 6.58%
Holding current value
$470,072
Previous $384,000 26.04%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.79 - $167.35 $24,077 - $33,637
201 Added 6.58%
3,254 $484,000
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $96,480 - $147,091
804 Added 35.75%
3,053 $384,000
Q1 2024

May 09, 2024

BUY
$170.78 - $208.42 $136,965 - $167,152
802 Added 55.43%
2,249 $413,000
Q4 2023

Feb 13, 2024

BUY
$114.17 - $185.35 $165,203 - $268,201
1,447 New
1,447 $260,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Nicolet Advisory Services, LLC Portfolio

Follow Nicolet Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Advisory Services, LLC with notifications on news.